Astrana Health, Inc. (ASTH) — Current Report

AI-Powered SEC Filing Analysis

← All ASTH filings

Want the newest filings?

This analysis covers the filing from 2026-03-30. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Earlier Current Report filings

Filed: 2026-03-02
  • Astrana Health expects to report a material weakness in its internal control over financial reporting, particularly related to acquisition and purchase accounting processes. This could raise concerns about the company's financial reporting quality.
  • The company plans to file its 2025 Form 10-K within the 15-day extension period, indicating potential delays in reporting annual results.
  • Astrana Health has increased the size of its share repurchase program from $50 million to $100 million, signaling management's confidence in the intrinsic value of the company's stock.
Filed: 2026-01-12
  • Astrana Health, Inc. updated its corporate presentation, indicating potential new developments or initiatives the company plans to present at upcoming conferences and meetings.
  • The company's filing notes that the information in the presentation is being furnished and not 'filed', suggesting the content may be more aspirational or forward-looking in nature.
  • The company cautions that it does not undertake to update the information in the presentation, which could signal the content is subject to change or uncertainty.

Other reports for Astrana Health, Inc.

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.